 Drug Labeling
"Drug Labeling" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information.
| Descriptor ID |
D004348
|
| MeSH Number(s) |
E05.916.310 J01.576.655.750.321.400 J01.576.761.300.400
|
| Concept/Terms |
Drug Labeling- Drug Labeling
- Labeling, Drug
- Drug Labelling
- Labelling, Drug
- Package Inserts, Drug
- Drug Package Insert
- Drug Package Inserts
- Insert, Drug Package
- Inserts, Drug Package
- Package Insert, Drug
- Product Labeling, Drug
- Drug Product Labeling
- Labeling, Drug Product
Black Box Warning- Black Box Warning
- Black Box Warnings
- Box Warning, Black
- Box Warnings, Black
- Warning, Black Box
- Warnings, Black Box
- Boxed Warning
- Boxed Warnings
- Warning, Boxed
- Warnings, Boxed
|
Below are MeSH descriptors whose meaning is more general than "Drug Labeling".
Below are MeSH descriptors whose meaning is more specific than "Drug Labeling".
This graph shows the total number of publications written about "Drug Labeling" by people in this website by year, and whether "Drug Labeling" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 | | 2011 | 3 | 0 | 3 | | 2016 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Labeling" by people in Profiles.
-
DeGroot J, Anderson LN, Chen Y, Birken CS, Parkin PC, Carsley S, Khovratovich M, Mamdani M, Maguire JL. Mandatory labeling requirements and over-the-counter cough and cold medication use in early childhood. Can J Public Health. 2016 Mar 16; 106(8):e477-82.
-
Gomes T, Juurlink DN, Moore I, Maguire JL, Mamdani MM. The impact of federal warnings on publically funded desmopressin utilization among children in Ontario. J Pediatr Urol. 2012 Jun; 8(3):249-53.
-
Peterson B, Hébert PC, MacDonald N, Rosenfield D, Stanbrook MB, Flegel K. Industry's neglect of prescribing information for children. CMAJ. 2011 Jun 14; 183(9):994-5.
-
Narayanan UG. Botulinum toxin: does the black box warning justify change in practice? Dev Med Child Neurol. 2011 Feb; 53(2):101-2.
-
Finkelstein Y, Rezvani M, Garcia-Bournissen F, Nurmohamed L, Koren G. Inactive pharmaceutical ingredients : implications for pregnancy. Can J Clin Pharmacol. 2007; 14(1):e17-28.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|